Acute Myelocytic Leukemia

Search Trials
Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia
Status:
Completed
Last Changed:
Oct 31, 2014
First Changed:
May 4, 2006
Disease(s):
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
Intervention(s):
total-body irradiationallogeneic hematopoietic stem cell transplantationcyclophosphamidemycophenolate mofetilbusulfancyclosporinefludarabine phosphateperipheral blood stem cell transplantationnonmyeloablative allogeneic hematopoietic stem cell transplantationlaboratory biomarker analysiscytogenetic analysisflow cytometryfluorescence in situ hybridizationpharmacological studypolymorphism analysistacrolimusmethotrexate
WEE1 Inhibitor AZD1775 With or Without Cytarabine in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome
Status:
Completed
Last Changed:
Sep 6, 2019
First Changed:
Jan 28, 2016
Disease(s):
Chronic Myelomonocytic Leukemia
Intervention(s):
CytarabineLaboratory Biomarker AnalysisPharmacological StudyQuality-of-Life AssessmentQuestionnaire AdministrationWEE1 Inhibitor AZD1775
Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy
Status:
Active, not recruiting
Last Changed:
Nov 18, 2021
First Changed:
Jun 5, 2013
Disease(s):
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
Intervention(s):
SirolimusAzacitidine
Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome
Status:
Completed
Last Changed:
Jan 2, 2018
First Changed:
Mar 9, 2007
Disease(s):
Adult Acute Myeloid Leukemia in Remission
Intervention(s):
cyclophosphamidebusulfantacrolimusmethotrexatecytogenetic analysisflow cytometrypharmacological studypharmacogenomic studiesperipheral blood stem cell transplantationallogeneic hematopoietic stem cell transplantation
Lenalidomide Maintenance Therapy in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
Status:
Terminated
Last Changed:
Sep 27, 2013
First Changed:
Jul 23, 2008
Disease(s):
Myelodysplastic Syndromes
Intervention(s):
lenalidomide

Connect. Empower. Inspire.